CPHI
CHINA PHARMA HOLDINGS, INC.
Key Financials
Operating Income
$-3239078
↑ 29.4%
Gross Profit
$-131950
↑ 93.4%
Revenue
$4.1M
↓ 8.5%
Net Income
$-3187556
↑ 32.7%
Total Liabilities
$8.3M
↑ 15.7%
EPS (Diluted)
$-0.74
↓ 174.1%
Total Assets
$31.0M
↑ 108.2%
Cash & Equivalents
$345112.00
↓ 42.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 5/15/2026 | View on SEC |
| 10-K | 4/1/2026 | View on SEC |
| NT 10-K | 4/1/2026 | View on SEC |
| 8-K | 3/3/2026 | View on SEC |
| 8-K | 2/10/2026 | View on SEC |
| 8-K | 1/6/2026 | View on SEC |
| 8-K | 12/23/2025 | View on SEC |
| 8-K | 12/10/2025 | View on SEC |
| DEF 14A | 11/14/2025 | View on SEC |
| 10-Q | 11/12/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CPHI |
| Company Name | CHINA PHARMA HOLDINGS, INC. |
| CIK | 1106644 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | NYSE |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 8689866811730 |